Synthesis of novel substituted purine derivatives and identification of the cell death mechanism
dc.citation.epage | 720 | en_US |
dc.citation.spage | 701 | en_US |
dc.citation.volumeNumber | 89 | en_US |
dc.contributor.author | Demir, Z. | en_US |
dc.contributor.author | Guven, E.B. | en_US |
dc.contributor.author | Ozbey, S. | en_US |
dc.contributor.author | Kazak, C. | en_US |
dc.contributor.author | Atalay, R.C. | en_US |
dc.contributor.author | Tuncbilek, M. | en_US |
dc.date.accessioned | 2016-02-08T10:03:30Z | |
dc.date.available | 2016-02-08T10:03:30Z | |
dc.date.issued | 2015 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | Novel substituted adenine and purine derivatives were designed and synthesized.Compound 36 displayed the greatest cytotoxic activity with IC50 less than 1 1/4M.36 induces senescence associated cell death, which was demonstrated with SA2-Gal assay. © 2014 Elsevier Masson SAS. | en_US |
dc.description.provenance | Made available in DSpace on 2016-02-08T10:03:30Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2015 | en |
dc.identifier.doi | 10.1016/j.ejmech.2014.10.080 | en_US |
dc.identifier.issn | 2235234 | |
dc.identifier.uri | http://hdl.handle.net/11693/22691 | |
dc.language.iso | English | en_US |
dc.publisher | Elsevier Masson SAS | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.ejmech.2014.10.080 | en_US |
dc.source.title | European Journal of Medicinal Chemistry | en_US |
dc.subject | Adenine | en_US |
dc.subject | Cytotoxic activity | en_US |
dc.subject | Hepatocellular carcinoma | en_US |
dc.subject | Purine derivatives | en_US |
dc.subject | Senescence | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | purine | en_US |
dc.subject | purine derivative | en_US |
dc.subject | cell death | en_US |
dc.subject | cell proliferation | en_US |
dc.subject | chemical structure | en_US |
dc.subject | chemistry | en_US |
dc.subject | dose response | en_US |
dc.subject | drug effects | en_US |
dc.subject | drug screening | en_US |
dc.subject | HCT116 cell line | en_US |
dc.subject | HepG2 cell line | en_US |
dc.subject | human | en_US |
dc.subject | structure activity relation | en_US |
dc.subject | synthesis | en_US |
dc.subject | tumor cell culture | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Cell Death | en_US |
dc.subject | Cell Proliferation | en_US |
dc.subject | Dose-Response Relationship, Drug | en_US |
dc.subject | Drug Screening Assays, Antitumor | en_US |
dc.subject | HCT116 Cells | en_US |
dc.subject | Hep G2 Cells | en_US |
dc.subject | Humans | en_US |
dc.subject | Models, Molecular | en_US |
dc.subject | Molecular Structure | en_US |
dc.subject | Purines | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.subject | Tumor Cells, Cultured | en_US |
dc.title | Synthesis of novel substituted purine derivatives and identification of the cell death mechanism | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.pdf
- Size:
- 5.82 MB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version